TrialMedicine2019

Circulating alarin concentrations are high in patients with type 2 diabetes and increased by glucagon-like peptide-1 receptor agonist treatment: An Consort-compliant study.

Wenjing Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.